Bessemer Group
MYOV

Bessemer Group’s Myovant Sciences Ltd. MYOV Stock Holding History

Bessemer Group’s Portfolio MYOV Stock Details MYOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-277
Closed -$4K – 2072
2022
Q1 		$4K Hold
277
– – ﹤0.01% 1650
2021
Q4 		$4K Hold
277
– – ﹤0.01% 1698
2021
Q3 		$6K Hold
277
– – ﹤0.01% 1497
2021
Q2 		$6K Hold
277
– – ﹤0.01% 1419
2021
Q1 		$6K Buy
+277
New +$6.31K ﹤0.01% 1385

Other funds holding MYOV

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bessemer Group's MYOV Position: Q2 2022 in Review

Bessemer Group sold out of Myovant Sciences Ltd. (MYOV) in Q2 2022, closing a stake of 277 shares — an estimated $4K sold.

Bessemer Group first reported a position in MYOV in Q1 2021 and held it in 5 quarters. The position peaked at $6K in Q3 2021. 91 funds tracked by Wall St. Rank hold MYOV as of Q2 2022.

  • Bessemer Group reported no remaining Myovant Sciences Ltd. position as of Q2 2022 after selling out during the quarter.
  • Bessemer Group sold 277 Myovant Sciences Ltd. shares in Q2 2022, an estimated $4K.
  • Bessemer Group first reported a position in Myovant Sciences Ltd. in Q1 2021 and held it in 5 quarters.
  • Bessemer Group's Myovant Sciences Ltd. position peaked at $6K in Q3 2021.
  • 91 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q2 2022.

Based on Bessemer Group's 13F filing for Q2 2022, filed 10 Aug 2022.